Skip to content

Frontlight ResearchEarly access

Trial site

Institutul Oncologic Prof.Dr. Ion Chiricuta Cluj-Napoca (Site 2501)

Cluj-Napoca, Cluj 400015, RomaniaEU-13 widening countryNot linked to an institution yet

1running trial

The trials here

What the trial at this site is about, from its registry record.

Conditions: Kidney cancer

Running trials

Active, not recruiting
A Study of Belzutifan (MK-6482) in Combination With Lenvatinib Versus Cabozantinib for Treatment of Renal Cell Carcinoma (MK-6482-011)
NCT04586231· Phase 3· Merck Sharp & Dohme LLC· Source

Site data: ClinicalTrials.govUpdated 12 Nov 2026

Report an error

Institutul Oncologic Prof.Dr. Ion Chiricuta Cluj-Napoca (Site 2501): trial site – Frontlight Research